跳至主要内容
临床试验/NCT00359697
NCT00359697Unknown1 期

Prospective, Randomized Clinical Trialto Compare Mannitol and Hypertonic Saline for Treatment of Increased Intracranial Pressure

Thomas Jefferson University0 个研究点目标入组 50 人开始时间: 2006年8月2日最近更新:
适应症
相关药物

试验速览

阶段
1 期
入组人数
50
主要终点
Reduction of ICP below treatment threshold (less than 20 mmHg)

研究概览

简要总结

The overall purpose of this study is to compare the effects of mannitol and hypertonic saline on patients with increased intracranial pressure. The hypothesis being tested is that hypertonic saline is more effective in controlling increased intracranial pressure than mannitol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Documented SAH (by computed tomography or lumbar puncture), ICH, TBI or brain tumor
  • Patient greater than or equal to 18 years of age
  • ICP monitor in place
  • ICP greater than 20mmHg, not related to a transient noxious stimulus and not responding to standard measures for controlling ICP (ventricular drainage, elevation of head of the bed and optimizing PaCO2)
  • Patient or patient's legally authorized representative has provided written informed consent

排除标准

  • Patient less than 18 years of age
  • Lack of ICP monitoring
  • Patient received Mannitol prior to placement of ICP monitor
  • Baseline serum osmolarity of greater than 310 mOsm/L
  • Patient is currently enrolled in another investigational drug or device study
  • Congestive heart failure at time of enrollment
  • Chronic renal failure on hemodialysis
  • Pregnancy

结局指标

主要结局

Reduction of ICP below treatment threshold (less than 20 mmHg)

次要结局

  • Compare effects of each treatment on MAP, CPP, serum and urine sodium and osmolality

研究者

申办方类型
Other
责任方
Sponsor

相似试验